Facial Rejuvenation Market Research Report Information By Product Type (Botulinum Toxin, Dermal Fillers, Chemical Peels, Topical Skin Care Products, Skin Rejuvenation Devices) and By End-User (Hospitals and Clinics, Dermatology Clinics, Others) – Forecast to 2032

Market Synopsis

Facial rejuvenation market is expected to reach USD 0.03 Billion at a 7.1% CAGR by 2032. Facial rejuvenation is a type of cosmetic treatment that uses non-invasive or minimally invasive procedures to restore the skin elasticity and improve the appearance of the skin. Growing demand for non-invasive aesthetic procedures, technological advancements by market players and changing lifestyle of the urban population are the key factors that are expected to drive the market growth. Moreover, the rising demand for quick results & shorter treatment durations and increasing popularity & awareness regarding facial rejuvenation are also expected to boost market growth.

Facial Rejuvenation Market Influencer

The increasing popularity of facial rejuvenation over invasive cosmetic procedures is expected to increase the demand for procedures.

Facial Rejuvenation Market Drivers

• Cost-effective alternative to cosmetic surgeries. In comparison to cosmetic surgeries, dermal fillers prove to be more reliable, affordable, and cost-effective. In 2018, the fees incurred by practitioners for facelift surgery was about USD 7,655, whereas, fees for facial rejuvenation using hyaluronic acid was just USD 682 in the US. This data demonstrates that fees of dermal fillers are quite low when compared to surgery, thus, increasing the preferability rates of dermal fillers.

• Rising demand for non-invasive aesthetic procedures

• Increasing R&D expenditure by companies to develop advanced treatments

• Change in the lifestyle of the urban population

• Rising demand for quick results and shorter treatment durations

• Growing awareness and popularity regarding facial rejuvenation

• Deeper penetration of cosmetic products in the local markets

Facial Rejuvenation Market Restraints

• Side effects associated with dermal fillers


• Lack of skilled professionals


• Growing availability of fraudulent products


• Lack of knowledge regarding product efficacy


• Improper standardization of regulations

Facial Rejuvenation Market Segmentation

By Product Type

• Botulinum Toxin: Increasing the number of product approvals and rising acceptance of botulinum toxin by consumers is expected to drive the market growth for the segment.

• Dermal Fillers: This segment held the largest market share in 2018 owing to its growing demand globally, increasing use of dermal fillers by the cosmetic surgeons, and its cost-effectiveness over other alternatives. Dermal Fillers are further segmented into hyaluronic acid, polymers & particles, calcium hydroxyapatite, and collagen.

• Chemical Peels: The rising popularity of chemical peels due to its regenerative effect on the skin is anticipated to drive the market growth.

• Topical Skin Care Products: Easy accessibility and usage over other products is expected to drive the market growth

• Skin Rejuvenation Devices: Technological advancements, wide adoption in the cosmetic industry, and long-lasting effects of the procedures are anticipated to drive the market growth. This segment is further segmented into intense pulsed light, microdermabrasion, laser-based devices, and ultrasound.

By End-User

• Hospitals and Clinics: This segment is expected to grow significantly, owing to the rising patient population.

• Dermatology Clinics: This segment is expected to demonstrate the fastest growth owing to its increasing popularity in developing countries.

• Others: This includes research and academic instituted and beauty centers, among others.

By Region

• 
  Americas: The largest regional market. Increase in the number of minimally invasive cosmetic procedures, high per capita disposable income, and increasing awareness about procedures related to dermal fillers. For instance, in 2017, about 17.5 million surgical and minimally invasive cosmetic procedures were performed in the US, with a 2% increase in the number of procedures over 2016. Thus, the demand for facial rejuvenation procedures has been increasing in the region, hence driving the market growth.

• 
  Europe: The Facial Rejuvenation market in Europe held the second-largest position in 2018 owing to the increasing acceptance of new aesthetic products and the increasing number of product approvals & availability of products across the region.

• 
  Asia-Pacific: The fastest-growing regional market. The growth of the facial rejuvenation market in this region is owing to rising per capita disposable income, escalating demand of facial aesthetics products, and increasing awareness about non-invasive cosmetic procedures available in the market.

• 
  Middle East & Africa: The market is expected to show the lowest growth due to limited access to treatment facilities and limited developments in technology.

Facial Rejuvenation Market Key Players

• Allergan (Ireland)


• Merz Pharma (Germany)


• Galderma (Switzerland)


• Lumenis (US)


• Revance (US)


• Contura Ltd (US)


• Anika Therapeutics, Inc. (US)


• Fibrocell Science, Inc. (US)


• Cynosure, A Hologic Company (US)


• Daewoong Co. Ltd (South Korea)


• Sinclair Pharma (UK)


• Teoxane Laboratories (Switzerland)


• Suneva Medical (US)


• Solta Medical, a Subsidiary of Bausch Health Companies (US)


• SciVision Biotech Inc. (Taiwan)